Dutch HealthTech EASE raises $9.5 million to expand access to advanced medical equipment in South Africa and Ghana

The funding came from AAFC Group Inc., a US-based investor specialising in emerging-market asset-backed finance, bringing total equity to $24 million.

Copy link to article
EASE-Holdings

Editor’s note: African-Startups is a sister publication of EU-Startups, bringing trusted coverage of startups, venture capital, and innovation across Africa.

EASE Holdings BV, the Netherlands-headquartered medical equipment-as-a-service provider, has secured $9.5 million in fresh equity.

The funding came from AAFC Group Inc., a US-based investor specialising in emerging-market asset-backed finance. The raise brings EASE’s total equity to $24 million.

“EASE is addressing a structural constraint: providers need access to increasingly sophisticated diagnostic and therapeutic technology, but the equity-to-debt ratios banks require make advanced medical equipment very expensive to own. As healthcare technology becomes increasingly AI-enabled, that challenge becomes more acute. EASE provides a solution that allows providers to keep pace,” said Frans van Schaik, CEO of AAFC Group Inc.

Headquartered in the Netherlands and operating across South Africa and Ghana, EASE provides hospitals, clinics and specialist practices with state-of-the-art medical equipment under pay-per-use or managed-service arrangements. This eliminates the massive upfront capital needed for many to open a hospital or other healthcare services.

The model not only provides the equipment but also covers equipment maintenance, technical support and technology upgrades, eliminating annual maintenance costs and allowing these costs to be treated as an operating expense rather than a capital outlay. The equipment categories include MRI, CT and PET-CT scanners, surgical robots and radiotherapy systems, the advanced tools needed for modern diagnostics and treatment but historically been out of reach for many African providers due to high ownership costs.

The company is led by Dr. Kanyinsola Oyeyinka, who was appointed CEO and Chair of the Management Board in May 2025 after previously serving as Senior Vice President since joining in 2022. Dr Oyeyinka brings a background that spans clinical medicine, health financing and investment banking across institutions including the Nigeria Sovereign Investment Authority, Deutsche Bank and the UK National Health Service.

“This investment marks an important step in expanding our healthcare infrastructure platform, which enables providers to deliver more diagnoses and treatments, while helping more patients access the care they need. We can now bring more high-value equipment to our customers and enable them to keep pace with AI and other technology advances,” said Dr Oyeyinka, CEO of EASE.

The fresh equity funding will be used to rapidly expand EASE’s installed base in South Africa and Ghana. The company has already completed select initial deployments including surgical robots in KwaZulu-Natal and Mpumalanga, a PET-CT scanner in Rustenburg, an MRI scanner in Akwatia, Ghana, and CT scanners in Accra.

The company says it plans to execute at least $20 million worth of new installations in South Africa alone in 2027, working alongside the country’s largest banks and leading equipment manufacturers. The company has also appointed Wynand du Plessis of Mindcor-InterSearch to recruit a managing director to aid with the expansion plans.

Beyond South Africa and Ghana, the company is also evaluating entry into additional markets, including India, Morocco, and Malaysia. With AI being embedded into medical imaging and surgical systems, EASE sees its equipment-as-a-service model becoming a durable solution to the growing technology gap in healthcare infrastructure across underserved markets.

Visited 44 times, 2 visit(s) today